miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - January 21, 2020 Category: Cancer & Oncology Authors: Xiao-Li Liu Wen-Gu Pan Kai-Lin Li Yi-Jie Mao Shuang-De Liu Rong-Mei Zhang Source Type: research